| Authors | Age | Location | Histology | Immunohistochemistry | Follow-up | Ref. |
| Tiltman and Knutzen | 50 | Vulva | Adenocarcinoma | Not done | 1 year | [3] | Kennedy and Majmudar | 54 | Vulva | Adenocarcinoma | CEA− CK+ | 10 years | [4] | 63 | Vulva | Adenocarcinoma | Not done | 4 years | Ghamande et al. | 80 | Vulva | Adenocarcinoma | CEA+ | 19 months | [5] | 67 | Vulva | Adenocarcinoma | CEA+ | 17 months | Willén et al. | 57 | Vulva | Adenocarcinoma | CEA+, CK+ | 26 months | [6] | Rodriguez et al. | 69 | Vulva | Adenocarcinoma | CEA+, CK7+, CK20+, ER−PR− | 36 months | [7] | Zaidi and Conner | 43 | Vulva | Adenocarcinoma | CEA+, CK+ | 18 months | [8] | Liu et al. | 49 | Vulva | Adenocarcinoma | Not done | 24 months | [9] | Dubé et al. | 58 | Vulva | Adenocarcinoma | CK7+, CK20+, CEA+ | 16 months | [10] | Cormio et al. | 58 42 | Vulva Vulva | Adenocarcinoma Adenocarcinoma | CK7+ CK20+/− | Death 39 months | [2] | Karkouche et al. | 31 | Vulva | Adenomas and adenocarcinoma | Adenomas; CK7−/CK20+ Adenocarcinoma; Not done | | [11] | Vitrey et al. | 57 | Vulva | Adenocarcinoma | CK7−CK20+ CDX2+, CA125+/− | 17 months | [12] | Musella et al. | 66 | Vulva | Tubulovillous adenoma | Not done | N/A | [13] | Ciano et al. | 72 | Vagina | Villous adenoma | Not done | 6 months | [14] | Ulbright et al. | 5 | Vagina | Papilloma | Not done | 12 months | [15] | Fox et al. | 35 | Vagina | Enteric adenocarcinoma | Not done | N/A | [16] | 59 | Vagina | Enteric adenocarcinoma | Not done | N/A | Mortensen and Nielsen | 43 | Vagina | Tubulovillous adenoma | CEA | N/A | [17] | Nagar et al. | 45 | Vagina | Adenocarcinoma | CK+, CEA+, p53+, ER−, PR−, | 18 months | [18] | Mudhar et al. | 56 | Vagina | Adenocarcinoma | CK7−, CK20+, CEA+ | 18 months | [19] | Werner et al. | 67 45 | Vagina Vagina | Adenocarcinoma Adenocarcinoma | CK7−, CK20−, CEA+ CK7+, CK20−, CEA− | 14 months 23 months | [20] | Dubé et al. | 64 | Vagina | Adenocarcinoma | CK7+, CK20+ | 18 months | [21] | Lee et al. | 61 | Vagina | Tubulovillous adenoma | CK7+, CK20+, p53± | N/A | [22] | Tjalma and Colpaert | 55 | Vagina | Adenocarcinoma | CK7+, CK20+, | N/A | [23] | van Wessel et al. | 68 | Vagina | Adenocarcinoma | CEA+, CK20+, CK7+ | 25 months | [24] |
|
|